Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
InSilixa logo — DNA TESTING FOR THE REST OF US

InSilixa

DNA TESTING FOR THE REST OF US

Founded 2011 United States Sunnyvale, United States 7 employees Venture round Total: $13.00M Biotechnology, Health Care

General Information

Company Name InSilixa
Founded Year 2011
Location United States Sunnyvale, United States
Employees 7
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with InSilixa. To contact InSilixa, visit insilixa.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does InSilixa compare?

A PDF of InSilixa and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting InSilixa soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About InSilixa

Insilixa is a Sunnyvale, CA-based biotechnology startup founded in 2011. The company is committed to revolutionizing molecular diagnostics through its innovative semiconductor-based CMOS biochip technology. With a team boasting expertise in semiconductor, biotechnology, medicine, and informatics sectors, Insilixa is dedicated to making molecular diagnostics more accessible and cost-effective on a global scale.

Having secured a $13.00M Venture Round investment from Morningside Ventures and PointGuard Ventures on 22 October 2014, the company is well-positioned for growth and impact in the biotechnology industry.

Insilixa's mission is to develop point-of-care and near-patient platforms that offer efficient, high-performance, and widely deployable solutions for DNA and protein-based diagnostic testing. Through its efforts, the company aims to drive affordable and high-performance molecular diagnostics, ultimately catering to the evolving needs of the healthcare sector.

Business keywords: Molecular Diagnostics, Semiconductor Technology, Biochip, CMOS Technology, Point-of-Care Testing, Near-Patient Platforms, DNA Testing, Protein Testing, Affordable Healthcare, Medical Technology, Informatics, Startup, Innovation, Sunnyvale, CA

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $13.00M 2
PointGuard Ventures
PointGuard Ventures, Morningside Group
22 Oct 2014

InSilixa Alternatives & Competitors

View All Alternatives
InSilixa vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
InSilixa vs
Xagenic
Xagenic

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduc...

Series B
Biotechnology, Health Care
InSilixa vs
Rivaara Labs
Rivaara Labs

Pioneering precision in diagnostics with timely, actionable solutions for better healthcare outcomes...

Private Equity
51-200 employees
Biotechnology, Health Care
View all alternatives

FAQ About InSilixa

DNA TESTING FOR THE REST OF US
InSilixa was founded in 2011.
InSilixa is headquartered in Sunnyvale, United States.
InSilixa operates in Biotechnology and Health Care. Its work centres on Molecular Diagnostics, Semiconductor Technology, Biochip and CMOS Technology.
InSilixa has approximately 7 employees.
InSilixa has completed 1 funding round, raising a total of $13.00M. The latest funding stage is Venture round.
Top alternatives and competitors to InSilixa include EMPE Diagnostics, Xagenic, Rivaara Labs, Molbio Diagnostics, Kenota Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InSilixa and EMPE Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for InSilixa, https://bouncewatch.com/company/insilixa, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes